Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

HealthEquity, Inc. (HQY) had Revenue of $1.20B for the most recently reported fiscal year, ending 2025-01-31.

Quarterly Annual

Figures for fiscal year ending 2025-01-31

Income Statement Financials
Revenue	$1.20B
Net Income	$96.70M
Cost of Goods Sold	$422.51M
Gross Profit	$777.26M
Operating Expenses	$1.04B
Operating Income	$162.33M
Non-Operating Income/Expense	$-46.30M
Pre-Tax Income	$116.03M
Normalized Pre-Tax Income	$116.03M
Income after Taxes	$96.70M
Income from Continuous Operations	$96.70M
Consolidated Net Income/Loss	$96.70M
Normalized Income after Taxes	$96.70M
EBIT	$162.33M
EBITDA	$326.85M
Weighted-Average Shares Outstanding (Basic)	86.87M
Weighted-Average Shares Outstanding (Diluted)	88.83M
Earnings per Share (EPS) (Basic)	$1.11
Earnings per Share (EPS) (Diluted)	$1.09
Balance Sheet Financials
Current Assets	$477.75M
Property, Plant, and Equipment	$3.24M
Long-Term Assets	$2.97B
Total Assets	$3.45B
Current Liabilities	$156.32M
Long-Term Debt	$1.06B
Long-Term Liabilities	$1.18B
Total Liabilities	$1.33B
Common Equity	$2.11B
Tangible Shareholders Equity	$-737.89M
Shareholders Equity	$2.11B
Common Shares Outstanding	86.54M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$339.86M
Cash Flow from Investing Activities	$-505.45M
Cash Flow from Financial Activities	$57.57M
Beginning Cash	$403.98M
End Cash	$295.95M
Increase/Decrease in Cash	$-108.03M
Stock-Based Compensation	$96.42M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.06
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.33
Debt to Equity Ratio	0.50
Gross Margin	64.78%
Operating Margin	13.53%
EBIT Margin	13.53%
EBITDA Margin	27.24%
Pre-Tax Profit Margin	9.67%
Profit Margin	8.06%
Free Cash Flow	$286.64M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.35
Inventory Turnover	--
Receiveable Turnover	10.17
Days Sales in Receivables	35.90
Return on Equity	4.57%
Return on Tangible Equity	-13.11%
Return on Assets	2.80%
Return on Investments	3.05%
Book Value Per Share	$24.44
Free Cash Flow per Share	$3.23
Operating Cash Flow per Share	$3.83

Data from Zacks Investment Research, Inc.